Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness in Chronic Kidney Disease
Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness
The first VA Biofabrication CoS Symposium will be held virtually May 4–5, 2022. We are excited to engage biofabrication researchers, practitioners, visionaries, and innovators like you to grow VA’s biofabrication efforts.
Join us for our panel discussion alongside Poietis on successful paths to commercialization on May 4th from 12:30 PM – 1:00 PM!
Biofabrication offers Veterans point-of-care solutions for the customized restoration of health. Through the VA Biofabrication Community of Science (Biofab CoS), VA is establishing an integrated infrastructure that aims to serve Veterans first with patient-matched biofabricated solutions.
Biofab CoS Provides:
Biofab CoS Initiatives:
Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness
Application Note: Bioprinting 3D Multi-cellular Cartilage Spheroids Using Laser-Assisted Technology View Paper Here
Publication Highlight: Single High-Dose Erythropoietin Disrupts Bone Homeostasis via Osteoclastogenic Pathways View Paper
Publication Highlight: Long-Term Optical Imaging Reveals Bone Marrow Clearance and Extramedullary Escape in
Publication Highlight: Overexpression of IL-32γ inhibits skin cancer formation through suppression of NF-κB
Publication Highlight: The role of phosphodiesterase 5 inhibitors in attenuating obesity-induced metabolic disorders